TY - JOUR
T1 - Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseases
AU - Willems, Esther
AU - Lorés-Motta, Laura
AU - Zanichelli, Andrea
AU - Suffritti, Chiara
AU - van der Flier, Michiel
AU - van der Molen, Renate G.
AU - Langereis, Jeroen D.
AU - van Drongelen, Joris
AU - van den Heuvel, Lambert P.
AU - Volokhina, Elena
AU - van de Kar, Nicole C.A.J.
AU - Keizer-Garritsen, Jenneke
AU - Levin, Michael
AU - Herberg, Jethro A.
AU - Martinon-Torres, Federico
AU - Wessels, Hans J.T.C.
AU - de Breuk, Anita
AU - Fauser, Sascha
AU - Hoyng, Carel B.
AU - den Hollander, Anneke I.
AU - de Groot, Ronald
AU - van Gool, Alain J.
AU - Gloerich, Jolein
AU - de Jonge, Marien I.
N1 - Funding Information:
We thank the PERFORM consortium for their collaboration and fruitful discussions. We also thank all healthy volunteers and the patients for donating their blood for these studies. This research, part of the PERFORM project, has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 668303.
Publisher Copyright:
© 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.
PY - 2020/11
Y1 - 2020/11
N2 - Objectives: Complement deficiencies are difficult to diagnose because of the variability of symptoms and the complexity of the diagnostic process. Here, we applied a novel ‘complementomics’ approach to study the impact of various complement deficiencies on circulating complement levels. Methods: Using a quantitative multiplex mass spectrometry assay, we analysed 44 peptides to profile 34 complement proteins simultaneously in 40 healthy controls and 83 individuals with a diagnosed deficiency or a potential pathogenic variant in 14 different complement proteins. Results: Apart from confirming near or total absence of the respective protein in plasma of complement-deficient patients, this mass spectrometry-based profiling method led to the identification of additional deficiencies. In many cases, partial depletion of the pathway up- and/or downstream of the absent protein was measured. This was especially found in patients deficient for complement inhibitors, such as angioedema patients with a C1-inhibitor deficiency. The added value of complementomics was shown in three patients with poorly defined complement deficiencies. Conclusion: Our study shows the potential clinical utility of profiling circulating complement proteins as a comprehensive read-out of various complement deficiencies. Particularly, our approach provides insight into the intricate interplay between complement proteins due to functional coupling, which contributes to the better understanding of the various disease phenotypes and improvement of care for patients with complement-mediated diseases.
AB - Objectives: Complement deficiencies are difficult to diagnose because of the variability of symptoms and the complexity of the diagnostic process. Here, we applied a novel ‘complementomics’ approach to study the impact of various complement deficiencies on circulating complement levels. Methods: Using a quantitative multiplex mass spectrometry assay, we analysed 44 peptides to profile 34 complement proteins simultaneously in 40 healthy controls and 83 individuals with a diagnosed deficiency or a potential pathogenic variant in 14 different complement proteins. Results: Apart from confirming near or total absence of the respective protein in plasma of complement-deficient patients, this mass spectrometry-based profiling method led to the identification of additional deficiencies. In many cases, partial depletion of the pathway up- and/or downstream of the absent protein was measured. This was especially found in patients deficient for complement inhibitors, such as angioedema patients with a C1-inhibitor deficiency. The added value of complementomics was shown in three patients with poorly defined complement deficiencies. Conclusion: Our study shows the potential clinical utility of profiling circulating complement proteins as a comprehensive read-out of various complement deficiencies. Particularly, our approach provides insight into the intricate interplay between complement proteins due to functional coupling, which contributes to the better understanding of the various disease phenotypes and improvement of care for patients with complement-mediated diseases.
KW - complement deficiencies
KW - complement system
KW - complement-mediated diseases
KW - complementomics
KW - multiplex targeted mass spectrometry
KW - pathway analysis
UR - https://www.scopus.com/pages/publications/85097993061
U2 - 10.1002/cti2.1225
DO - 10.1002/cti2.1225
M3 - Article
AN - SCOPUS:85097993061
SN - 2050-0068
VL - 9
JO - Clinical and Translational Immunology
JF - Clinical and Translational Immunology
IS - 12
M1 - e1225
ER -